Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its product...
Data could not be retrieved
| 500680 | Peers | Sector | |
|---|---|---|---|
Market Cap | 194.4 B | 372 B | 5.741 B |
Price % of 52 Week High | 65.8% | 83.2% | 61.5% |
Dividend Yield | 0.8% | 0.9% | 0.0% |
Shareholder Yield | 1.0% | 1.3% | -0.6% |
1 Year Price Total Return | 1.8% | 18.1% | -11.5% |
Beta (5 Year) | 0.21 | 0.41 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Mar-23 | Mar-24 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 24,248 | 21,932 | 22,361 | 5,400 | 5,380 |
| Operating Income | 7,046 | 5,770 | 6,480 | 1,350 | 1,312 |
| Net Profit | 6,239 | 5,513 | 6,155 | 1,300 | 1,276 |
| Diluted EPS | 136.38 | 120.51 | 134.53 | 28.42 | 27.89 |
| EBITDA | 7,704 | 5,985 | 6,363 | 1,515 | 1,366 |
| Balance Sheet | |||||
| Cash & ST Invest. | 18,484 | 20,273 | 22,813 | 18,922 | 22,813 |
| Current Assets | 25,251 | 27,696 | |||
| Total Assets | 40,007 | 42,288 | |||
| Current Liabilities | 6,574 | 5,466 | |||
| Total Liabilities | 7,934 | 6,332 | |||
| Total Equity | 32,073 | 35,955 | 37,509 | 32,730 | 37,509 |
| Total Debt | 1,345 | 945 | 747 | 1,160 | 747 |
| Cash Flow Statement | |||||
| Cash Flow Operations | 3,557 | 2,568 | |||
| Cash From Investing | (361) | 537 | |||
| Cash From Financing | (3,458) | (2,351) | |||
| Free Cash Flow | 2,907 | 2,379 | 4,014 | 0.00 | - |